IN2014MN02082A - - Google Patents
Info
- Publication number
- IN2014MN02082A IN2014MN02082A IN2082MUN2014A IN2014MN02082A IN 2014MN02082 A IN2014MN02082 A IN 2014MN02082A IN 2082MUN2014 A IN2082MUN2014 A IN 2082MUN2014A IN 2014MN02082 A IN2014MN02082 A IN 2014MN02082A
- Authority
- IN
- India
- Prior art keywords
- formula
- disclosed
- methods
- administering
- treating
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/305—Mercury compounds
- A61K31/31—Mercury compounds containing nitrogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Transplantation (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Psychiatry (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261614274P | 2012-03-22 | 2012-03-22 | |
| PCT/US2013/032575 WO2013142382A1 (fr) | 2012-03-22 | 2013-03-15 | Composés de pyridopyrimidine substituée et leur utilisation comme inhibiteurs de flt3 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014MN02082A true IN2014MN02082A (fr) | 2015-08-21 |
Family
ID=49223277
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN2082MUN2014 IN2014MN02082A (fr) | 2012-03-22 | 2013-03-15 |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US8877763B2 (fr) |
| EP (1) | EP2828259B1 (fr) |
| JP (1) | JP6101341B2 (fr) |
| KR (1) | KR102011770B1 (fr) |
| CN (1) | CN104428298B (fr) |
| AU (1) | AU2013235344B2 (fr) |
| BR (1) | BR112014023460B1 (fr) |
| CA (1) | CA2868156C (fr) |
| CL (1) | CL2014002505A1 (fr) |
| EA (1) | EA031267B1 (fr) |
| ES (1) | ES2694223T3 (fr) |
| HK (1) | HK1208453A1 (fr) |
| IL (1) | IL234802B (fr) |
| IN (1) | IN2014MN02082A (fr) |
| MX (1) | MX360912B (fr) |
| MY (1) | MY184858A (fr) |
| NZ (1) | NZ700283A (fr) |
| PL (1) | PL2828259T3 (fr) |
| SG (1) | SG11201405942RA (fr) |
| TR (1) | TR201816480T4 (fr) |
| WO (1) | WO2013142382A1 (fr) |
| ZA (1) | ZA201407588B (fr) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105940000B (zh) * | 2013-10-21 | 2019-12-24 | 盖诺斯克公司 | 取代的嘧啶化合物及其作为syk抑制剂的用途 |
| CN105272930B (zh) * | 2014-07-17 | 2018-07-13 | 广东东阳光药业有限公司 | 取代脲衍生物及其在药物中的应用 |
| KR20160035411A (ko) * | 2014-09-23 | 2016-03-31 | 주식회사 오스코텍 | LRRK2 (Leucine Rich Repeat Kinase 2) 키나제 억제제로서의 피리도피리미딘 유도체 화합물 |
| US11608340B2 (en) | 2014-11-17 | 2023-03-21 | Rhode Island Hospital | Nanomaterial compositions, synthesis, and assembly |
| BR112020026641A2 (pt) * | 2018-06-27 | 2021-03-30 | Oscotec Inc. | Derivados de piridopirimidinona para o uso como inibidores de axl |
| KR20200022712A (ko) * | 2018-08-23 | 2020-03-04 | 주식회사 오스코텍 | 8-브로모-2-(1-메틸피페리딘-4-일아미노)-4-(4-페녹시페닐아미노)피리도[4,3-d]피리미딘-5(6H)-온 염산염의 결정다형체 및 그 제조방법 |
| KR102230721B1 (ko) * | 2019-02-01 | 2021-03-22 | 주식회사 오스코텍 | 피리도피리미딘계 염산염을 포함하는 경구용 고형제제 및 이의 제조방법 |
| US20220143049A1 (en) | 2019-03-21 | 2022-05-12 | Onxeo | A dbait molecule in combination with kinase inhibitor for the treatment of cancer |
| CN110327347B (zh) * | 2019-08-16 | 2021-06-01 | 陕西科技大学 | G-749在制备抗真菌药物中的应用 |
| TWI759829B (zh) * | 2019-08-23 | 2022-04-01 | 財團法人生物技術開發中心 | 作為第iii型受體酪胺酸激酶抑制劑之雜環吡唑衍生物 |
| JP2023500906A (ja) | 2019-11-08 | 2023-01-11 | インサーム（インスティテュ ナシオナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシェ メディカル） | キナーゼ阻害剤に対する獲得抵抗性を有するがんの処置方法 |
| WO2021148581A1 (fr) | 2020-01-22 | 2021-07-29 | Onxeo | Nouvelle molécule dbait et son utilisation |
| WO2023027966A1 (fr) | 2021-08-24 | 2023-03-02 | Biomea Fusion, Inc. | Composés de pyrazine en tant qu'inhibiteurs irréversibles de flt3 |
| WO2023129667A1 (fr) | 2021-12-30 | 2023-07-06 | Biomea Fusion, Inc. | Composés pyrazines utilisés comme inhibiteurs de flt3 |
| WO2023225005A1 (fr) | 2022-05-17 | 2023-11-23 | Biomea Fusion, Inc. | Polythérapie à base de flt3 pour le cancer et compositions associées |
| KR102440707B1 (ko) | 2022-07-10 | 2022-09-05 | 이우미 | 공장 추천 시스템 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CZ20022521A3 (cs) * | 2000-01-27 | 2003-02-12 | Warner-Lambert Company | Pyridopyrimidinonové deriváty pro léčení neurodegenerativních onemocnění |
| AU9378401A (en) * | 2000-08-31 | 2002-03-13 | Hoffmann La Roche | 7-oxo pyridopyrimidines as inhibitors of a cellular proliferation |
| MXPA03001733A (es) * | 2000-08-31 | 2003-05-27 | Hoffmann La Roche | 7-oxo-piridopirimidinas. |
| EP2025678A1 (fr) * | 2007-08-17 | 2009-02-18 | Oncalis AG | Composés pyrazolo[3,4-d]pyrimidine et leur utilisation comme modulateur de protein kinase |
| TW200942537A (en) * | 2008-02-01 | 2009-10-16 | Irm Llc | Compounds and compositions as kinase inhibitors |
| WO2010019637A1 (fr) | 2008-08-12 | 2010-02-18 | Smithkline Beecham Corporation | Composés chimiques |
| US8338481B2 (en) * | 2009-01-28 | 2012-12-25 | Ramot At Tel-Aviv University Ltd. | Alkoxyalkyl S-prenylthiosalicylates for treatment of cancer |
| JP2013502429A (ja) * | 2009-08-19 | 2013-01-24 | アムビト ビオスシエンセス コルポラチオン | ビアリール化合物及びその使用方法 |
| EA029273B1 (ru) * | 2009-10-29 | 2018-03-30 | Джиноско | Киназные ингибиторы |
-
2013
- 2013-03-15 ES ES13763998.5T patent/ES2694223T3/es active Active
- 2013-03-15 AU AU2013235344A patent/AU2013235344B2/en active Active
- 2013-03-15 EP EP13763998.5A patent/EP2828259B1/fr active Active
- 2013-03-15 MY MYPI2014702705A patent/MY184858A/en unknown
- 2013-03-15 US US13/841,827 patent/US8877763B2/en active Active
- 2013-03-15 NZ NZ700283A patent/NZ700283A/en unknown
- 2013-03-15 MX MX2014011354A patent/MX360912B/es active IP Right Grant
- 2013-03-15 PL PL13763998T patent/PL2828259T3/pl unknown
- 2013-03-15 CN CN201380025782.8A patent/CN104428298B/zh active Active
- 2013-03-15 BR BR112014023460-4A patent/BR112014023460B1/pt active IP Right Grant
- 2013-03-15 EA EA201491747A patent/EA031267B1/ru not_active IP Right Cessation
- 2013-03-15 WO PCT/US2013/032575 patent/WO2013142382A1/fr active Application Filing
- 2013-03-15 JP JP2015501823A patent/JP6101341B2/ja active Active
- 2013-03-15 KR KR1020147029509A patent/KR102011770B1/ko active IP Right Grant
- 2013-03-15 SG SG11201405942RA patent/SG11201405942RA/en unknown
- 2013-03-15 TR TR2018/16480T patent/TR201816480T4/tr unknown
- 2013-03-15 IN IN2082MUN2014 patent/IN2014MN02082A/en unknown
- 2013-03-15 CA CA2868156A patent/CA2868156C/fr active Active
-
2014
- 2014-09-22 CL CL2014002505A patent/CL2014002505A1/es unknown
- 2014-09-22 IL IL234802A patent/IL234802B/en active IP Right Grant
- 2014-10-20 ZA ZA2014/07588A patent/ZA201407588B/en unknown
-
2015
- 2015-09-16 HK HK15109075.2A patent/HK1208453A1/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP2828259A4 (fr) | 2015-08-19 |
| EP2828259A1 (fr) | 2015-01-28 |
| KR20140144709A (ko) | 2014-12-19 |
| ZA201407588B (en) | 2015-11-25 |
| KR102011770B1 (ko) | 2019-08-19 |
| BR112014023460B1 (pt) | 2020-09-01 |
| MX2014011354A (es) | 2014-12-05 |
| TR201816480T4 (tr) | 2018-11-21 |
| CN104428298B (zh) | 2017-03-01 |
| NZ700283A (en) | 2016-08-26 |
| AU2013235344B2 (en) | 2017-03-16 |
| CA2868156A1 (fr) | 2013-09-26 |
| ES2694223T3 (es) | 2018-12-19 |
| HK1208453A1 (en) | 2016-03-04 |
| WO2013142382A1 (fr) | 2013-09-26 |
| SG11201405942RA (en) | 2014-10-30 |
| AU2013235344A1 (en) | 2014-10-09 |
| EP2828259B1 (fr) | 2018-08-08 |
| CL2014002505A1 (es) | 2015-10-02 |
| CN104428298A (zh) | 2015-03-18 |
| JP2015510942A (ja) | 2015-04-13 |
| US20130274274A1 (en) | 2013-10-17 |
| EA201491747A1 (ru) | 2015-10-30 |
| MX360912B (es) | 2018-11-22 |
| JP6101341B2 (ja) | 2017-03-22 |
| EA031267B1 (ru) | 2018-12-28 |
| CA2868156C (fr) | 2020-07-28 |
| IL234802B (en) | 2018-10-31 |
| MY184858A (en) | 2021-04-27 |
| US8877763B2 (en) | 2014-11-04 |
| PL2828259T3 (pl) | 2019-02-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2014MN02082A (fr) | ||
| PH12019501321A1 (en) | Methods of treating or preventing cholesterol related disorders | |
| PH12018500041A1 (en) | Substituted aza compoounds as irak-4 inhibitors | |
| PH12014502757B1 (en) | Dihydronaphthyridines and related compounds useful as kinase inhibitors for the treatment of proliferative diseases | |
| MY178621A (en) | Deuterated cftr potentiators | |
| TN2013000348A1 (en) | Compounds and compositions as trk inhibitors | |
| NZ700928A (en) | Dna-pk inhibitors | |
| MX344335B (es) | Derivados de benzonitrilo como inhibidores de cinasa. | |
| IN2015DN01156A (fr) | ||
| MX361815B (es) | Compuestos pirazolopirimidinicos como inhibidores de cinasas. | |
| MX2020004183A (es) | Compuestos aromaticos multisustituidos como inhibidores de serina proteasa. | |
| WO2013134336A3 (fr) | Inhibition de la kinase 1 associée à un adaptateur pour le traitement de la douleur | |
| EA023222B8 (ru) | Пиразолилхиноксалиновые ингибиторы киназы | |
| WO2014028600A3 (fr) | Composés 3-aminocycloalkyl utilisés en tant qu'inhibiteurs de rorgammat et utilisations de ceux-ci | |
| MX2014005928A (es) | Inhibidores ciclicos de glutaminasa. | |
| MX344302B (es) | Compuestos de quinazolina sustituidos con alquino y metodos uso. | |
| SG10201805392YA (en) | 1,2,4-triazine-6-carboxamide kinase inhibitors | |
| IN2014DN07224A (fr) | ||
| IN2015MN00002A (fr) | ||
| PH12016500735A1 (en) | Substituted pyrimidine compounds and their use as syk inhibitors | |
| EA201590744A1 (ru) | Лечение рака tor киназными ингибиторами | |
| IN2014DN07220A (fr) | ||
| NZ707773A (en) | Methods of treating liver diseases | |
| WO2014160177A3 (fr) | Inhibiteurs quinazolines de pi3k | |
| IN2014DN07954A (fr) |